The economic impact of invasive aspergillosis in intensive care unit patients

International Journal of Infectious Diseases

Volumn 14, Issue 6, 2010, Pages

  Blot, Stijn ^a,b,c   Piette, Anne ^a   Vandijck, Dominique ^b   Lizy, Christelle ^b   Vandewoude, Koenraad ^a,b   Vogelaers, Dirk ^a,b,c  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY COLLEGE GHENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED STUDY; COST OF ILLNESS; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; INVASIVE ASPERGILLOSIS; LENGTH OF STAY; LETTER; RENAL REPLACEMENT THERAPY; VENTILATED PATIENT;

ASPERGILLOSIS; HEALTH CARE COSTS; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; RENAL REPLACEMENT THERAPY; RESPIRATION, ARTIFICIAL; TIME FACTORS;

EID: 77952240073     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2009.06.014     Document Type: Letter

References (10)

1. Denning D.W. Invasive aspergillosis. Clin Infect Dis 26 (1998) 781-803 quiz 804-5
2. Vandewoude K., Vogelaers D., and Blot S. Aspergillosis in the ICU-the new 21st century problem. Med Mycol 44 (2006) S71-S76
3. Tong K.B., Lau C.J., Murtagh K., Layton A.J., and Seifeldin R. The economic impact of aspergillosis: analysis of hospital expenditures across patient subgroups. Int J Infect Dis 13 (2009) 24-36
4. Blot S., and Vandewoude K. Management of invasive candidiasis in critically ill patients. Drugs 64 (2004) 2159-2175
5. Vandewoude K., Blot S., Benoit D., Depuydt P., Vogelaers D., and Colardyn F. Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality. Acta Clin Belg 59 (2004) 251-257
6. Vandewoude K.H., Blot S.I., Depuydt P., Benoit D., Temmerman W., Colardyn F., et al. Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 10 (2006) R31
7. Vandijck D., Blot S., Labeau S., Buyle F.M., Depaemelaere M., Vandewoude K., et al. Candidemia in critically ill patients: an analysis of daily antifungal therapy related costs. J Mycol Med 18 (2008) 96-99
8. Blot S., De Bacquer D., Hoste E., Depuydt P., Vandewoude K., De Waele J., et al. Influence of matching for exposure time on estimates of attributable mortality caused by nosocomial bacteremia in critically ill patients. Infect Control Hosp Epidemiol 26 (2005) 352-356
9. Blot S., Depuydt P., Vandewoude K., and De Bacquer D. Measuring the impact of multidrug resistance in nosocomial infection. Curr Opin Infect Dis 20 (2007) 391-396
10. Vandewoude K.H., Blot S.I., Benoit D., Colardyn F., and Vogelaers D. Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence. J Hosp Infect 56 (2004) 269-276